Skip to main content

Advertisement

SpringerLink
Log in

Cancer therapy

RET inhibitors go tumor-agnostic

  • Year in Review
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This year saw breakthroughs in several fields, spurred by research in basic science and technology. Here is our selection of critical developments that moved medicine forward in 2022.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Nature Medicine http://www.nature.com/nm/

    Karen O’Leary

Authors
  1. Karen O’Leary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen O’Leary.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Leary, K. RET inhibitors go tumor-agnostic. Nat Med 28, 2449 (2022). https://doi.org/10.1038/s41591-022-02131-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-02131-4

  • Springer Nature America, Inc.

Search

Navigation